{ "entity_id": "B-004497", "folder": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "type": "Advisory Body", "jurisdiction": "Commonwealth", "portfolio": "Health, Disability and Ageing", "website": "https://www.health.gov.au/committees-and-groups/australian-brain-cancer-mission-expert-advisory-panel", "data_status": "partial", "completeness": { "has_strategy_brief": true, "has_strategy_structured": true, "has_vision": false, "has_kpi_targets": true, "has_kpi_results": false, "has_strategy_overview": true, "has_legislation_text": true, "has_legislation_structured": false, "has_global_initiatives_text": false, "has_global_initiatives_structured": false, "n_global_initiatives": 0, "has_ideas": true, "has_artifacts": true, "n_ideas": 12, "n_legislation": 0, "n_artifacts": 8, "n_kpi_targets": 5, "n_kpi_results": 0, "n_outcomes": 3, "verified_own_data": true }, "strategy_profile": { "status": "needs_review", "confidence": "medium", "summary": "To conduct innovative, interdisciplinary, collaborative and translational preclinical brain cancer research projects that advance knowledge in at least one of these areas:\n• Aetiology of brain cancer;\n• Identification and validation of new therapeutic strategies for brain cancer; and/or\n• Development of new therapies for brain cancer.", "official_site_url": "https://www.health.gov.au/committees-and-groups/australian-brain-cancer-mission-expert-advisory-panel", "source_documents": [ { "type": "strategie", "title": "MRFF Australian Brain Cancer Mission strategic documents [PDF - 269 KB] - 2 pages", "url": "https://www.health.gov.au/sites/default/files/2025-03/mrff-australian-brain-cancer-mission-strategic-documents.pdf", "period": "2025", "confidence": "medium" }, { "type": "strategie", "title": "MRFF Australian Brain Cancer Mission strategic documents [PDF - 479 KB] - 10 pages", "url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "period": "2025", "confidence": "medium" }, { "type": "strategie", "title": "Australian Brain Cancer Research Roadmap [PDF - 354 KB] - 2 pages", "url": "https://www.health.gov.au/sites/default/files/documents/2022/07/australian-brain-cancer-research-roadmap.pdf", "period": "2022", "confidence": "medium" }, { "type": "strategie", "title": "Standard for AI transparency statements", "url": "https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf", "period": "2024", "confidence": "medium" } ], "purpose": null, "vision": null, "strategic_priorities": [], "values": [ { "name": "Innovation", "description": "", "source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "source_page": null }, { "name": "Collaboration", "description": "", "source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "source_page": null }, { "name": "Support for Researchers", "description": "", "source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "source_page": null }, { "name": "Equity", "description": "", "source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "source_page": null } ], "outcomes": [ { "name": "AIM 1: Improve understanding of brain cancer biology", "description": "To conduct innovative, interdisciplinary, collaborative and translational preclinical brain cancer research projects that advance knowledge in at least one of these areas:\n• Aetiology of brain cancer;\n• Identification and validation of new therapeutic strategies for brain cancer; and/or\n• Development of new therapies for brain cancer.", "activities": [ "Conduct innovative, interdisciplinary, collaborative and translational preclinical brain cancer research projects", "Adopt innovative approaches to brain cancer research", "Empower and champion Early- and Mid-Career Researchers", "Involve health care services, including regional, rural and remote health care services" ], "source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "source_page": 4, "source_deep_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf#page=4" }, { "name": "AIM 2: Improve survival for children and adults with brain cancer", "description": "To conduct innovative, interdisciplinary, collaborative and translational pre-clinical and/or early-stage clinical brain cancer research projects that advance knowledge in at least two of these areas:\n• Aetiology of brain cancer;\n• Identification and validation of new therapeutic strategies for brain cancer; and/or\n• Development of new therapies for brain cancer.", "activities": [ "Conduct innovative, interdisciplinary, collaborative and translational pre-clinical and/or early-stage clinical brain cancer research projects", "Adopt innovative approaches to brain cancer research", "Empower and champion Early- and Mid-Career Researchers", "Involve health care services, including regional, rural and remote health care services" ], "source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "source_page": 6, "source_deep_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf#page=6" }, { "name": "AIM 3: Improve quality of life for people affected by brain cancer", "description": "To develop novel approaches to reduce treatment toxicity and adverse effects of brain cancer treatment for patients, to minimise the short- and/or long-term negative impacts for patients and carers.", "activities": [ "Measure the negative impacts of brain cancer treatments", "Improve the quality of life for people affected by brain cancer", "Empower and champion Early- and Mid-Career Researchers", "Involve health care services, including regional, rural and remote health care services" ], "source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "source_page": 7, "source_deep_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf#page=7" } ], "performance_measures": [ { "code": "AIM1-1", "measure": "Understanding the factors associated with the aetiology of brain cancer", "target": "Improve understanding of brain cancer biology", "latest_result": "", "status": "", "target_source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "target_source_page": 4, "result_source_url": "", "result_source_page": null }, { "code": "AIM1-2", "measure": "Understanding factors associated with the mechanisms of treatment resistance", "target": "Improve understanding of brain cancer biology", "latest_result": "", "status": "", "target_source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "target_source_page": 4, "result_source_url": "", "result_source_page": null }, { "code": "AIM2-1", "measure": "Identifying and developing new therapeutic strategies for brain cancer", "target": "Improve survival for children and adults with brain cancer", "latest_result": "", "status": "", "target_source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "target_source_page": 6, "result_source_url": "", "result_source_page": null }, { "code": "AIM2-2", "measure": "Improving diagnostic strategies for disease identification and treatment monitoring", "target": "Improve survival for children and adults with brain cancer", "latest_result": "", "status": "", "target_source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "target_source_page": 6, "result_source_url": "", "result_source_page": null }, { "code": "AIM3-1", "measure": "Creating and evaluating innovative approaches for improving the quality of life of people affected by brain cancer", "target": "Improve quality of life for people affected by brain cancer", "latest_result": "", "status": "", "target_source_url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "target_source_page": 7, "result_source_url": "", "result_source_page": null } ], "document_alignment_terms": { "must_support": [], "watch_terms": [ "Understanding the factors associated with the aetiology of brain cancer", "Understanding factors associated with the mechanisms of treatment resistance", "Identifying and developing new therapeutic strategies for brain cancer", "Improving diagnostic strategies for disease identification and treatment monitoring", "Creating and evaluating innovative approaches for improving the quality of life of people affected by brain cancer" ], "avoid_claiming_without_evidence": [] }, "review_note": "Structured strategy exists but is incomplete." }, "global_initiatives": null, "strategy": { "reporting_period": "2024-25", "corporate_plan_period": "2025-26", "vision": null, "vision_source_page": null, "purposes": null, "purposes_source_page": null, "how_we_deliver": null, "how_we_deliver_source_page": null, "government_priorities": [], "outcomes": [ { "name": "AIM 1: Improve understanding of brain cancer biology", "description": "To conduct innovative, interdisciplinary, collaborative and translational preclinical brain cancer research projects that advance knowledge in at least one of these areas:\n• Aetiology of brain cancer;\n• Identification and validation of new therapeutic strategies for brain cancer; and/or\n• Development of new therapies for brain cancer.", "key_activities": [ "Conduct innovative, interdisciplinary, collaborative and translational preclinical brain cancer research projects", "Adopt innovative approaches to brain cancer research", "Empower and champion Early- and Mid-Career Researchers", "Involve health care services, including regional, rural and remote health care services" ], "source_page": 4 }, { "name": "AIM 2: Improve survival for children and adults with brain cancer", "description": "To conduct innovative, interdisciplinary, collaborative and translational pre-clinical and/or early-stage clinical brain cancer research projects that advance knowledge in at least two of these areas:\n• Aetiology of brain cancer;\n• Identification and validation of new therapeutic strategies for brain cancer; and/or\n• Development of new therapies for brain cancer.", "key_activities": [ "Conduct innovative, interdisciplinary, collaborative and translational pre-clinical and/or early-stage clinical brain cancer research projects", "Adopt innovative approaches to brain cancer research", "Empower and champion Early- and Mid-Career Researchers", "Involve health care services, including regional, rural and remote health care services" ], "source_page": 6 }, { "name": "AIM 3: Improve quality of life for people affected by brain cancer", "description": "To develop novel approaches to reduce treatment toxicity and adverse effects of brain cancer treatment for patients, to minimise the short- and/or long-term negative impacts for patients and carers.", "key_activities": [ "Measure the negative impacts of brain cancer treatments", "Improve the quality of life for people affected by brain cancer", "Empower and champion Early- and Mid-Career Researchers", "Involve health care services, including regional, rural and remote health care services" ], "source_page": 7 } ], "values": [ "Innovation", "Collaboration", "Support for Researchers", "Equity" ], "values_framework_name": "Not specified", "kpi_targets_2025_26": [ { "code": "AIM1-1", "measure": "Understanding the factors associated with the aetiology of brain cancer", "target": "Improve understanding of brain cancer biology", "source_page": 4 }, { "code": "AIM1-2", "measure": "Understanding factors associated with the mechanisms of treatment resistance", "target": "Improve understanding of brain cancer biology", "source_page": 4 }, { "code": "AIM2-1", "measure": "Identifying and developing new therapeutic strategies for brain cancer", "target": "Improve survival for children and adults with brain cancer", "source_page": 6 }, { "code": "AIM2-2", "measure": "Improving diagnostic strategies for disease identification and treatment monitoring", "target": "Improve survival for children and adults with brain cancer", "source_page": 6 }, { "code": "AIM3-1", "measure": "Creating and evaluating innovative approaches for improving the quality of life of people affected by brain cancer", "target": "Improve quality of life for people affected by brain cancer", "source_page": 7 } ], "kpi_results_2024_25": [], "_source_urls": { "annual_report_url": "", "corporate_plan_url": "" } }, "ideas": [ { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Data & Performance", "scale": "small", "title": "KPI evidence register with named owners", "idea": "Create a simple register mapping each KPI to source data, owner, frequency, target, and last result.", "quote": "E.1 US Department of Defence grant funding structure\nAward Key Mechanism Elements Funding\nMechanism\nConcept Award ■ Supports highly innovative, non-incremental, high ■ Maximum funding of\nrisk/potentially high-reward lung cancer research. $100,000 in direct costs\n(plus indirect costs).\n■ Emphasis on innovation.\n■ Period of performance\n■ Clinical trials are not allowed.\nshould not exceed 1 year\n■ Preliminary data are not required.\n■ Relevance to military health is strongly encouraged.\n■ Care Delivery and Health Disparity category must address one\nor more of the Disparities, Health Outcomes, and Survivorship\nAreas of Emphasis.\n■ Cancer Research Continuum category must address at least\none or more of the nine cancer continuum-focused Areas of\nEmphasis.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "other-pdfs/review-of-the-australian-brain-cancer-mission.pdf (https://www.health.gov.au/sites/default/files/2023-12/review-of-the-australian-brain-cancer-mission.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Data & Performance", "scale": "large", "title": "Outcome dashboard linking budget, delivery, and public impact", "idea": "Build a public-facing outcome dashboard showing spend, outputs, outcomes, and delivery confidence.", "quote": "E.1 US Department of Defence grant funding structure\nAward Key Mechanism Elements Funding\nMechanism\nConcept Award ■ Supports highly innovative, non-incremental, high ■ Maximum funding of\nrisk/potentially high-reward lung cancer research. $100,000 in direct costs\n(plus indirect costs).\n■ Emphasis on innovation.\n■ Period of performance\n■ Clinical trials are not allowed.\nshould not exceed 1 year\n■ Preliminary data are not required.\n■ Relevance to military health is strongly encouraged.\n■ Care Delivery and Health Disparity category must address one\nor more of the Disparities, Health Outcomes, and Survivorship\nAreas of Emphasis.\n■ Cancer Research Continuum category must address at least\none or more of the nine cancer continuum-focused Areas of\nEmphasis.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "other-pdfs/review-of-the-australian-brain-cancer-mission.pdf (https://www.health.gov.au/sites/default/files/2023-12/review-of-the-australian-brain-cancer-mission.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Procurement & Delivery", "scale": "small", "title": "Procurement lessons library for repeat purchases", "idea": "Capture reusable procurement clauses, market lessons, supplier performance notes, and common evaluation criteria.", "quote": "[Page 10]\nOpportunities to use additional investment and other research to support\nthe priority areas include, but are not limited to, the following:\n• Mission Funding Partner investments\n• MRFF initiatives, Missions and grant opportunities (such as the Emerging Priorities and\nConsumer-Driven Research Initiative's 2024 Paediatric Brain Cancer Research Grant\nOpportunity, Genomics Health Futures Mission, Clinical Trials Activity initiative, Research\nData Infrastructure, National Critical Research Infrastructure, MRFF funding for rural\nresearch streams, and the Early to Mid-Career Researchers initiative)\n• The Australian Government through:\nthe National Health and Medical Research Council (NHMRC)\no\nthe Australian Research Council\no\nCancer Australia\no\nother government investment\no\n• State and territory governments\n• Corporate, philanthropic and investment funds", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Delivery teams / suppliers", "source": "strategies/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf (https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Procurement & Delivery", "scale": "large", "title": "Portfolio delivery office for major investments", "idea": "Stand up a portfolio delivery office that tracks benefits, risks, dependencies, procurement, and delivery confidence.", "quote": "[Page 10]\nOpportunities to use additional investment and other research to support\nthe priority areas include, but are not limited to, the following:\n• Mission Funding Partner investments\n• MRFF initiatives, Missions and grant opportunities (such as the Emerging Priorities and\nConsumer-Driven Research Initiative's 2024 Paediatric Brain Cancer Research Grant\nOpportunity, Genomics Health Futures Mission, Clinical Trials Activity initiative, Research\nData Infrastructure, National Critical Research Infrastructure, MRFF funding for rural\nresearch streams, and the Early to Mid-Career Researchers initiative)\n• The Australian Government through:\nthe National Health and Medical Research Council (NHMRC)\no\nthe Australian Research Council\no\nCancer Australia\no\nother government investment\no\n• State and territory governments\n• Corporate, philanthropic and investment funds", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Delivery teams / suppliers", "source": "strategies/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf (https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Citizen Participation", "scale": "small", "title": "Consultation feedback summaries with response tracking", "idea": "Summarise consultation submissions by theme and publish what changed in response.", "quote": "Development of an evaluation and stakeholder management plan\nAn evaluation and stakeholder management plan were developed for this review which:\n■ set out a fit-for-purpose program logic (see chart 1.4) that aligns with the MRFF\nMonitoring, Evaluation and Learning Strategy 2021-22 to 2023-24 (Evaluation\nStrategy) to review progress towards MRFF outcome and impact measures, and\nalignment with the goals and priorities of the Mission\n■ provided a search strategy for the literature review to support an environmental scan\nof the brain cancer research landscape\n■ identified how literature would be collated and assessed to draw insight for the\npurpose of the Mission evaluation, and\n■ set out a proposed consultation strategy, including the type of information to be\ncollected from surveys, and from semi-structured interviews.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "other-pdfs/review-of-the-australian-brain-cancer-mission.pdf (https://www.health.gov.au/sites/default/files/2023-12/review-of-the-australian-brain-cancer-mission.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Citizen Participation", "scale": "large", "title": "Always-on policy participation platform", "idea": "Create a standing participation platform where citizens and stakeholders can propose, vote, and track ideas.", "quote": "Development of an evaluation and stakeholder management plan\nAn evaluation and stakeholder management plan were developed for this review which:\n■ set out a fit-for-purpose program logic (see chart 1.4) that aligns with the MRFF\nMonitoring, Evaluation and Learning Strategy 2021-22 to 2023-24 (Evaluation\nStrategy) to review progress towards MRFF outcome and impact measures, and\nalignment with the goals and priorities of the Mission\n■ provided a search strategy for the literature review to support an environmental scan\nof the brain cancer research landscape\n■ identified how literature would be collated and assessed to draw insight for the\npurpose of the Mission evaluation, and\n■ set out a proposed consultation strategy, including the type of information to be\ncollected from surveys, and from semi-structured interviews.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "other-pdfs/review-of-the-australian-brain-cancer-mission.pdf (https://www.health.gov.au/sites/default/files/2023-12/review-of-the-australian-brain-cancer-mission.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Citizen Services", "scale": "small", "title": "Plain-language service pages and proactive status updates", "idea": "Rewrite high-volume pages and letters into plain language, add status notifications, and measure contact reduction.", "quote": "[Page 117]\nB.1 Funding partner contributions to the Australian Brain Cancer Mission (July 2023)\nFunding contribution ($m)\nCommitted Total\nFunding Category of MRFF Other to projects to committed\npartner funding Activity Institution projects projects date to Mission*\nACT Health and Staff Provision of a Brain Cancer Specialist Nurse Canberra Health Service 0.36 1.82 3.95\nCanberra\nHealth Services Equipment grant Provision of stereotactic treatment Canberra Health Service 0.30\nOther Brain tumour multi-disciplinary team meeting Canberra Health Service 0.29\nOther Brain tumour multi-disciplinary meeting Canberra Health Service 0.14\nClinical trial Canberra Health services research and clinical trials Canberra Health Service 0.14\nResearch grant Research grant: Research and innovation fund ACT Health Directorate 0.29", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Citizens / service users", "source": "other-pdfs/review-of-the-australian-brain-cancer-mission.pdf (https://www.health.gov.au/sites/default/files/2023-12/review-of-the-australian-brain-cancer-mission.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Citizen Services", "scale": "large", "title": "Single front door for life-event based services", "idea": "Bundle services around life events so citizens can complete related steps across agencies in one journey.", "quote": "[Page 117]\nB.1 Funding partner contributions to the Australian Brain Cancer Mission (July 2023)\nFunding contribution ($m)\nCommitted Total\nFunding Category of MRFF Other to projects to committed\npartner funding Activity Institution projects projects date to Mission*\nACT Health and Staff Provision of a Brain Cancer Specialist Nurse Canberra Health Service 0.36 1.82 3.95\nCanberra\nHealth Services Equipment grant Provision of stereotactic treatment Canberra Health Service 0.30\nOther Brain tumour multi-disciplinary team meeting Canberra Health Service 0.29\nOther Brain tumour multi-disciplinary meeting Canberra Health Service 0.14\nClinical trial Canberra Health services research and clinical trials Canberra Health Service 0.14\nResearch grant Research grant: Research and innovation fund ACT Health Directorate 0.29", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Citizens / service users", "source": "other-pdfs/review-of-the-australian-brain-cancer-mission.pdf (https://www.health.gov.au/sites/default/files/2023-12/review-of-the-australian-brain-cancer-mission.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Risk & Assurance", "scale": "small", "title": "Recommendation tracker for audits, reviews, and inquiries", "idea": "Publish a single internal tracker for audit/review recommendations, owners, due dates, and implementation evidence.", "quote": "2.17 ICRP brain cancer projects by CSO and Cancer Australia Audit of Australia brain\ncancer funding, 2018-2020\nICRP Treatment CA Audit\n5% Biology 0% 0%\n9% 13%\n34% Early Detection, Diag. &\n10%\nProg.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "other-pdfs/review-of-the-australian-brain-cancer-mission.pdf (https://www.health.gov.au/sites/default/files/2023-12/review-of-the-australian-brain-cancer-mission.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Risk & Assurance", "scale": "large", "title": "Integrated assurance and lessons-learned system", "idea": "Create an assurance system that connects audit findings, risk registers, delivery reviews, and investment decisions.", "quote": "2.17 ICRP brain cancer projects by CSO and Cancer Australia Audit of Australia brain\ncancer funding, 2018-2020\nICRP Treatment CA Audit\n5% Biology 0% 0%\n9% 13%\n34% Early Detection, Diag. &\n10%\nProg.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "other-pdfs/review-of-the-australian-brain-cancer-mission.pdf (https://www.health.gov.au/sites/default/files/2023-12/review-of-the-australian-brain-cancer-mission.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Regulation & Policy", "scale": "small", "title": "Regulatory burden scan for forms, guidance, and reporting", "idea": "Identify the top 10 highest-friction reporting obligations and simplify guidance, forms, or evidence requirements.", "quote": "[pages 1,2,3,4,5]\n[Page 1]\nDeclarations of Interest Policy Statement\nPurpose\nTo ensure members of MRFF advisory panels, committees, groups and other bodies identify\nand declare relevant interests and that the Health and Medical Research Office (HMRO)\nmanages these interests appropriately.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "other-pdfs/medical-research-future-fund-declaration-of-interest-policy-statement_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/medical-research-future-fund-declaration-of-interest-policy-statement_0.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "category": "Regulation & Policy", "scale": "large", "title": "Adaptive regulation program with live feedback loops", "idea": "Create an adaptive regulation model using sandboxes, industry data, risk scoring, and regular rule updates.", "quote": "[pages 1,2,3,4,5]\n[Page 1]\nDeclarations of Interest Policy Statement\nPurpose\nTo ensure members of MRFF advisory panels, committees, groups and other bodies identify\nand declare relevant interests and that the Health and Medical Research Office (HMRO)\nmanages these interests appropriately.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "other-pdfs/medical-research-future-fund-declaration-of-interest-policy-statement_0.pdf (https://www.health.gov.au/sites/default/files/documents/2021/12/medical-research-future-fund-declaration-of-interest-policy-statement_0.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] } ], "legislation_administered": [], "artifacts": [ { "category": "strategies", "year": "2025", "url": "https://www.health.gov.au/sites/default/files/2025-03/mrff-australian-brain-cancer-mission-strategic-documents.pdf", "file": "strategies/mrff-australian-brain-cancer-mission-strategic-documents.pdf", "bytes": 275077, "link_text": "MRFF Australian Brain Cancer Mission strategic documents [PDF - 269 KB] - 2 pages" }, { "category": "strategies", "year": "2025", "url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "file": "strategies/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "bytes": 490435, "link_text": "MRFF Australian Brain Cancer Mission strategic documents [PDF - 479 KB] - 10 pages" }, { "category": "strategies", "year": "2022", "url": "https://www.health.gov.au/sites/default/files/documents/2022/07/australian-brain-cancer-research-roadmap.pdf", "file": "strategies/australian-brain-cancer-research-roadmap.pdf", "bytes": 362448, "link_text": "Australian Brain Cancer Research Roadmap [PDF - 354 KB] - 2 pages" }, { "category": "strategies", "year": "2024", "url": "https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf", "file": "strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf", "bytes": 289017, "link_text": "Standard for AI transparency statements" }, { "category": "other-pdfs", "year": "2025", "url": "https://www.health.gov.au/sites/default/files/2025-03/appendix_a_-_mrff_australian_brain_cancer_mission_projects_funded_as_of_november_2024.pdf", "file": "other-pdfs/appendix_a_-_mrff_australian_brain_cancer_mission_projects_funded_as_of_november.pdf", "bytes": 118488, "link_text": "MRFF Australian Brain Cancer Mission strategic documents [PDF - 116 KB] - 3 pages" }, { "category": "other-pdfs", "year": "2025", "url": "https://www.health.gov.au/sites/default/files/2025-03/appendix_b_-_funding_partner_contributions_to_the_australian_brain_cancer_mission_as_of_november_2024.pdf", "file": "other-pdfs/appendix_b_-_funding_partner_contributions_to_the_australian_brain_cancer_missio.pdf", "bytes": 179395, "link_text": "MRFF Australian Brain Cancer Mission strategic documents [PDF - 176 KB] - 10 pages" }, { "category": "other-pdfs", "year": "2023", "url": "https://www.health.gov.au/sites/default/files/2023-12/review-of-the-australian-brain-cancer-mission.pdf", "file": "other-pdfs/review-of-the-australian-brain-cancer-mission.pdf", "bytes": 1701496, "link_text": "Review of the Australian Brain Cancer Mission [PDF - 2 MB] - 142 pages" }, { "category": "other-pdfs", "year": "2021", "url": "https://www.health.gov.au/sites/default/files/documents/2021/12/medical-research-future-fund-declaration-of-interest-policy-statement_0.pdf", "file": "other-pdfs/medical-research-future-fund-declaration-of-interest-policy-statement_0.pdf", "bytes": 286828, "link_text": "Medical Research Future Fund Declaration of Interest Policy Statement [PDF - 281 KB] - 5 pages" } ], "_meta": { "snapshot_built_at": "2026-05-14T02:13:11+00:00", "strategy_brief_meta": { "model": "nova-micro", "folder": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "annual_report": { "file": null, "url": "", "year": null }, "corporate_plan": { "file": "strategies\\mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.txt", "url": "https://www.health.gov.au/sites/default/files/2025-03/mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025.pdf", "year": "mrff_australian_brain_cancer_mission_implementation_plan_-_february_2025" }, "usage": { "input_tokens": 4104, "output_tokens": 945, "total_tokens": 5049, "model": "nova-micro" }, "cost_usd": 0.00027594, "elapsed_seconds": 4.8, "generated_at": "2026-05-13T05:17:28+00:00" }, "ideas_manifest": { "entity_id": "B-004497", "entity_name": "MRFF Australian Brain Cancer Mission Expert Advisory Panel", "folder_name": "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel", "generated_at": "2026-05-09T23:06:05.637976+00:00", "idea_count": 12, "markdown": "ideas/MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel_ideas.md", "jsonl": "ideas/ideas.jsonl", "inputs": [ "MRFF-Australian-Brain-Cancer-Mission-Expert-Advisory-Panel_strategy-overview.md", "strategy-evidence.json", "global-intelligence/source-manifest.json" ] }, "global_intel_meta": null } }